Mr. Saba’s experience includes patent cases involving pharmaceuticals, biotechnology, consumer electronics, and microphone technologies, both in U.S. District Courts and Section 337 investigations before the U.S. International Trade Commission. Mr. Saba has substantial experience in patent litigation brought under the Hatch Waxman Act, including cases involving method of treatment and formulation patents.
Mr. Saba has also represented pro bono individual clients in a variety of criminal and civil matters, including successfully representing a criminal defendant in a jury trial in Maryland state court and obtaining asylum for a client in an evidentiary hearing before a federal immigration judge.
- J.D., University of Maryland School of Law (summa cum laude) (Moot Court) (Order of the Coif), 2011
- B.S.E., University of Michigan, Chemical Engineering (magna cum laude), 2008
- District of Columbia
- U.S. Patent and Trademark Office
- U.S. Court of Appeals for the Federal Circuit
Publications and Presentations
- Panelist, “Definitely, Maybe: Determining Patentable Subject Matter and the Future of Section 101,” ACI Paragraph IV Disputes Conference, April 2021
- Co-author, Trial in ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, American Bar Association (Section of Intellectual Property Law), 2020